Capnia names former Glaxo, Alza chief Ernest Mario as CEO
Capnia, a little-known Palo Alto, Calif., biotech, named former Glaxo and Alza head Ernest Mario as CEO. See our story in today’s daily briefing at VentureBeat Life Sciences.
Next Story: AutekBio raises $1.1M for contract cell lines
Previous Story: Life sciences briefing: Tuesday, Aug. 7, 2007
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.
VentureBeat Writers
- Matt Marshall, Editor-in-Chief
- Dean Takahashi, Lead Writer, GamesBeat
- Anthony Ha, Assistant Editor, VentureBeat
- Camille Ricketts, Lead Writer, GreenBeat
- Paul Boutin, Writer, VentureBeat
- Kim-Mai Cutler, Writer, VentureBeat
- Matthaus Krzykowski, Mobile Consultant & Coordinator
VentureBeat Start-Up Index
An index of the hottest startups, measured by trends in their traffic, news coverage, buzz and funding.